The purpose of this continuing professional development supplement is to explain how an integrated summary report can be created to consolidate the information required for assessment of immunogenicity-related risks of different types of biopharmaceuticals.
Join now to get access to:
Not sure yet? Read one of our free editorials to see what you’re missing out on!